We have safe and effective vaccines, therapeutics, and diagnostics—but to end the pandemic, we need to ensure everyone has access to them. This week, BIO President and CEO Dr. Michelle McMurry-Heath explained how we can boost access, both at home and abroad.
“The global pandemic can only be ended with global efforts that reach everywhere this deadly virus is prevalent,”said BIO’s Dr. Michelle McMurry-Heath in a letter yesterday to President Biden.
The letter highlights the importance of the COVAX and ACT Accelerator initiatives, which will deliver vaccines to poor and underdeveloped countries. (One of the Biden administration’s first actions was announcing the United States will participate in them.)
The letter also highlights concerns with the World Health Organization’s proposed TRIPS waiver,which would temporarily waive intellectual property rights for COVID-19 vaccines and drugs and “distract from the need for coordinated international efforts and the cooperative work that currently is being advanced, and thus ultimately undermine the very goals of quick, safe access that it seeks to promote.”
What about underrepresented communities right here in the United States? “Until officials address [vaccine] hesitancy systematically, it will obstruct vaccination efforts—long after vaccine supply and delivery concerns are resolved,” she writes in an op-ed for the New Jersey Star-Ledger, co-authored by Dr. Shereef Elnahal, President and CEO of University Hospital in Newark.
“But here’s who can sway them: pastors, family doctors, and other trusted local influencers—even hairstylists,” they continue. “With help from community pillars, we can convince a critical mass to get vaccinated.”
Read the whole thing to learn how.
More Health Care News:
Reuters: Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study
“The scientists said the neutralizing ability was roughly equivalent to the vaccine’s effect on a previous less contagious version of the virus from last year.”
STAT News: A pandemic expert weighs in on the long road ahead for COVID-19 vaccine distribution
CEPI will “launch the strategy for its next set of goals and take part in an important discussion at the London think tank Chatham House aimed at finding ways to unblock the vaccine production bottlenecks without harming non-COVID vaccine production.”